We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
+25.05%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$73.8B
AUM Growth
-$45B
(-38%)
Cap. Flow
-$66.7B
Cap. Flow
% of AUM
-90.35%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
3,841
New
51
Increased
330
Reduced
2,079
Closed
1,309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tyson Foods
TSN
|
+$184M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$161M |
| 3 |
Royalty Pharma
RPRX
|
+$161M |
| 4 |
SBA Communications
SBAC
|
+$148M |
| 5 |
American Homes 4 Rent
AMH
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.36B |
| 2 |
Apple
AAPL
|
+$1.23B |
| 3 |
Amazon
AMZN
|
+$1.14B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$628M |
| 5 |
Meta Platforms (Facebook)
META
|
+$602M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 12.19% |
| 3 | Healthcare | 12.05% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FUSN
1251
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $3.21M | ﹤0.01% |
+183,725
| New | +$3.2M |
|
1252
Emergent Biosolutions
EBS
$248M
| $3.2M | ﹤0.01% |
40,497
+26,265
| +185% | +$1.96M |
|
1253
Bruker
BRKR
$8.14B
| $3.2M | ﹤0.01% |
78,718
-85,048
| -52% | -$3.35M |
|
1254
Haemonetics
HAE
$4B
| $3.19M | ﹤0.01% |
35,586
-27,030
| -43% | -$2.73M |
|
|
BIG
1255
DELISTED
Big Lots, Inc.
BIG
| $3.17M | ﹤0.01% |
75,552
-51,136
| -40% | -$1.45M |
|
1256
B&G Foods
BGS
$286M
| $3.15M | ﹤0.01% |
129,395
-229,589
| -64% | -$4.97M |
|
|
TSE
1257
DELISTED
Trinseo
TSE
| $3.15M | ﹤0.01% |
142,187
-65,487
| -32% | -$1.34M |
|
1258
Trustmark
TRMK
$2.75B
| $3.15M | ﹤0.01% |
128,300
-106,422
| -45% | -$2.56M |
|
1259
Penumbra
PEN
$12.8B
| $3.14M | ﹤0.01% |
17,573
+5,113
| +41% | +$887K |
|
|
NGHC
1260
DELISTED
National General Holdings Corp
NGHC
| $3.14M | ﹤0.01% |
145,117
-67,447
| -32% | -$1.27M |
|
1261
Aurinia Pharmaceuticals
AUPH
$2.11B
| $3.13M | ﹤0.01% |
192,853
-192,853
| -50% | -$3.09M |
|
|
VIVO
1262
DELISTED
Meridian Bioscience Inc
VIVO
| $3.12M | ﹤0.01% |
133,752
-186,918
| -58% | -$2.71M |
|
1263
Acushnet Holdings
GOLF
$5.45B
| $3.11M | ﹤0.01% |
89,507
+31,679
| +55% | +$940K |
|
1264
OneMain Financial
OMF
$7.47B
| $3.1M | ﹤0.01% |
126,327
-47,307
| -27% | -$1.08M |
|
1265
Repligen
RGEN
$9.25B
| $3.1M | ﹤0.01% |
25,035
-27,329
| -52% | -$3.22M |
|
1266
Aramark
ARMK
$14.7B
| $3.09M | ﹤0.01% |
189,893
-3,833,945
| -95% | -$67.3M |
|
1267
National Healthcare
NHC
$3.38B
| $3.09M | ﹤0.01% |
48,653
-48,845
| -50% | -$3.27M |
|
1268
PolyPid
PYPD
$92.8M
| $3.06M | ﹤0.01% |
+5,667
| New | +$3.17M |
|
1269
Moderna
MRNA
$23.6B
| $3.06M | ﹤0.01% |
47,725
-27,503
| -37% | -$1.51M |
|
1270
NeoGenomics
NEO
$2.13B
| $3.06M | ﹤0.01% |
98,670
-450,344
| -82% | -$12.5M |
|
|
KZR
1271
DELISTED
Kezar Life Sciences
KZR
| $3.04M | ﹤0.01% |
58,757
-215,248
| -79% | -$10.9M |
|
1272
Construction Partners
ROAD
$6.77B
| $3.03M | ﹤0.01% |
170,380
-117,216
| -41% | -$2M |
|
1273
Comfort Systems
FIX
$59.6B
| $3.02M | ﹤0.01% |
73,982
-8,166
| -10% | -$290K |
|
1274
US Foods
USFD
$24B
| $3.01M | ﹤0.01% |
152,490
-845,676
| -85% | -$16.2M |
|
1275
National Health Investors
NHI
$3.65B
| $3M | ﹤0.01% |
49,437
-18,113
| -27% | -$995K |
|
Similar funds
VGA
Victory Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Victory Capital Management held 3,841 positions worth $73.8B, down 38% from $119B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Victory Capital Management withdrew a net $66.7B in Q2 2020, closing 1,309 positions and reducing 2,079 holdings. Its most notable exit was AMES National, an estimated $91.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Victory Capital Management opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $170M.
- Victory Capital Management's largest Q2 2020 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,558,761 shares worth $170M.
- Victory Capital Management added most to Tyson Foods in Q2 2020, an estimated $184M increase.
- Victory Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $1.36B.
- Victory Capital Management fully exited AMES National in Q2 2020, selling an estimated $91.4M.
- Victory Capital Management's ten largest holdings make up 9.4% of its $73.8B portfolio in Q2 2020.
- Victory Capital Management opened 51 new positions and closed 1,309 in Q2 2020.
- Victory Capital Management's portfolio value fell 38% quarter-over-quarter to $73.8B.
Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.